New Research Opportunities in Washington
Are you interested in conducting clinical research, participating in a clinical
study, clinical trials in Washington.
Vanguard Research Group Consortium Sites in Washington include:
Bremerton – zip 98311
Are you interested in performing clinical research, participating in a clinical study, clinical trials in Washington.
The Vanguard Research Group specializes in clinical research in the behavioral health community. The organization is a joint venture with Northwell Health, New York’s largest health care provider. VRG is a Contract Research Organization or CRO that provides clinical trial services for the pharmaceutical, biotechnology, and medical device industries, in addition to some federally funded studies too.
VRG is looking to connect with community treatment centers and academic mental health sites in Washington interested in partnering with our network.
Are you interested in becoming a potential participant or take part in clinical trials in your area in Washington? To learn more about our upcoming studies or to participate in one of our clinical studies in Washington contact VRG, and our staff can guide you through finding the right clinical study for you, and how to connect with a local treatment center in Washington.
At The Vanguard Research Group we work directly with Sponsors and other Contract Research Organization to support clinical trials in Washington. We can provide either full or partial service CRO services including performing site feasibility, selection, contracting, payment, trial management, IRB submissions, data collection and so much more. Learn more about the services that VRG can do for you by clicking the button below.
Do you manage a community mental health center in Washington and want to investigate the chance to participate in research? Or are you already conducting clinical trials and want to explore more opportunities? The Vanguard Research Group is eager to help you further in clinical research or clinical study trials in Washington. Contact The Vanguard Research Group today.